Gibson Robert J 4
4 · Scopus BioPharma Inc. · Filed Feb 26, 2021
Insider Transaction Report
Form 4
Gibson Robert J
DirectorVice Chairman
Transactions
- Purchase
Common Stock, par value $0.001
2021-02-24$9.46/sh+150$1,419→ 150 total - Purchase
Common Stock, par value $0.001
2021-02-25$9.29/sh+150$1,393→ 300 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.41 to $9.65 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.22 to $9.49 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4.